Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › NE › LINCOLN › PEDIATRICS, P.C.

PEDIATRICS, P.C.

NPI: 1194904201 · LINCOLN, NE 68510 · Pediatrics Physician · NPI assigned 10/25/2007

$1.84M
Total Medicaid Paid
31,558
Total Claims
29,550
Beneficiaries
33
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialFISHER, TRACY (OFFICE MANAGER)
NPI Enumeration Date10/25/2007

Related Entities

Other providers sharing the same authorized official: FISHER, TRACY

ProviderCityStateTotal Paid
TRACY WENDY FISHER CYPRESS TX $771K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 2,558 $174K
2019 3,456 $210K
2020 4,302 $221K
2021 6,938 $330K
2022 6,370 $406K
2023 4,317 $269K
2024 3,617 $231K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 15,297 14,011 $1.03M
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 2,675 2,474 $254K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 1,838 1,668 $154K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 1,617 1,593 $146K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 634 618 $57K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 391 374 $47K
90688 2,045 2,022 $34K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 885 848 $29K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 39 38 $15K
90670 822 815 $12K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 117 115 $11K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 443 436 $9K
96127 305 251 $8K
99177 948 922 $7K
92551 416 407 $6K
90723 364 363 $5K
90680 336 335 $5K
90647 313 311 $5K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 19 19 $2K
99383 14 14 $2K
99382 15 15 $2K
90633 90 90 $1K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 85 85 $1K
90658 88 88 $960.96
90716 41 41 $592.96
90707 40 40 $573.14
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 20 18 $376.20
0071A 13 13 $372.50
96110 Developmental screening, with scoring and documentation, per standardized instrument 27 27 $352.14
90687 18 18 $196.56
90651 13 13 $119.42
99072 927 864 $0.00
96161 663 604 $0.00